Moolec Science (MLEC) Share-based Compensation (2022 - 2024)
Moolec Science's (MLEC) quarterly Share-based Compensation came in at $2.0 million in Q4 2024, down 7.34% year-on-year from $2.2 million in Q1 2024, and up 614.3% quarter-over-quarter from $285560.0 in Q3 2024.
Moolec Science (MLEC) Share-based Compensation (2022 - 2024) Analysis & Trends
Moolec Science has disclosed Share-based Compensation across 3 years of filings, most recently posting $2.0 million for Q4 2024.
- Share-based Compensation for Q4 2024 came in at $2.0 million, down 7.34% year-over-year; the trailing twelve-month figure through Dec 2024 was $2.0 million (down 7.34% YoY), and the FY2025 annual result was $4.4 million, up 29.69% from the prior year.
- Share-based Compensation came in at $2.0 million for Q4 2024 at Moolec Science, up from $285560.0 in the prior quarter.
- In the past five years, Share-based Compensation ranged from a high of $12.6 million in Q2 2024 to a low of $285560.0 in Q3 2024.
- The 3-year median for Share-based Compensation is $2.1 million (2023), against an average of $3.2 million.
- Across the five-year window, Share-based Compensation soared 298.92% in 2023 and plunged 83.61% in 2024, its largest moves.
- Moolec Science's Share-based Compensation stood at $551841.0 in 2022, then jumped by 298.92% to $2.2 million in 2023, then dropped by 7.34% to $2.0 million in 2024.
- The last three Share-based Compensation figures came in at $2.0 million (Q4 2024), $285560.0 (Q3 2024), and $12.6 million (Q2 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Share-based Compensation (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 723,416.35 Bn | 723,416.32 Bn | - | - |
| 2 | Belite Bio | 57,340.00 Bn | 57,340.00 Bn | - | - |
| 3 | Quantum Biopharma | 19,125.08 Bn | 19,125.08 Bn | - | - |
| 4 | Legend Biotech | 3,262.00 Bn | 3,261.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,789.67 Bn | 1,789.67 Bn | - | 305,000.00 |
| 6 | Evaxion A | 1,480.39 Bn | 1,480.37 Bn | - | - |
| 7 | Psyence Biomedical | 241.78 Bn | 241.78 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.54 Bn | 106.29 Bn | 2.59 Bn | 166.40 Mn |
| 9 | Abivax | 94.26 Bn | 94.26 Bn | - | 26.47 Mn |
| 10 | Moolec Science | 6.98 Bn | 6.98 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 2.04 Mn |
| Dec 31, 2024 | 2.04 Mn |
| Sep 30, 2024 | 285,560.00 |
| Sep 30, 2024 | 285,560.00 |
| Jun 30, 2024 | 12.56 Mn |
| Jun 30, 2024 | 12.56 Mn |
| Mar 31, 2024 | 2.97 Mn |
| Mar 31, 2024 | 2.97 Mn |
| Dec 31, 2023 | 2.20 Mn |
| Dec 31, 2023 | 2.20 Mn |
| Sep 30, 2023 | 1.74 Mn |
| Sep 30, 2023 | 1.74 Mn |
| Jun 30, 2023 | 3.40 Mn |
| Jun 30, 2023 | 3.40 Mn |
| Dec 31, 2022 | 551,841.00 |
| Dec 31, 2022 | 551,841.00 |